Advertisement
News
Subscribe to MDT Magazine News

Boston Scientific Responds to DOJ Civil Lawsuit

January 28, 2011 4:32 am | by Boston Scientific | Comments

NATICK, Mass., Jan. 28, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that yesterday afternoon, the Civil Division of the U.S. Department of Justice (DOJ) filed a civil False Claims Act compla

TOPICS:

Myriad Genetics 2Q profit slides on tax costs(2)

January 28, 2011 3:46 am | by The Associated Press | Comments

Molecular diagnostics company Myriad Genetics Inc. said its profit fell 32 percent in the fiscal second quarter as its tax expenses increased.Myriad said Thursday its net income declined to $24.2 million, or 26 cents per share, from $35.4 million, or 36 cents per share, a year earlier. Revenue...

Myriad Genetics 2Q profit slides on tax costs

January 28, 2011 3:45 am | Comments

Molecular diagnostics company Myriad Genetics Inc. said its profit fell 32 percent in the fiscal second quarter as its tax expenses increased.Myriad said Thursday its net income declined to $24.2 million, or 26 cents per share, from $35.4 million, or 36 cents per share, a year earlier. Revenue...

Advertisement

Device Packaging Conference and Exhibition Overview(2)

January 28, 2011 2:34 am | by I-Micronews | Comments

The seventh Annual Device Packaging Conference (DPC2011) will be held in Scottsdale, Arizona, on March 7-10, 2011. It is an international event sponsored and organized by the International Microelectronics And Packaging Society (IMAPS).

Device Packaging Conference and Exhibition Overview

January 28, 2011 2:33 am | Comments

The seventh Annual Device Packaging Conference (DPC2011) will be held in Scottsdale, Arizona, on March 7-10, 2011. It is an international event sponsored and organized by the International Microelectronics And Packaging Society (IMAPS).

Endo Pharmaceuticals and Orion Corporation Begin Novel R & D Collaboration

January 27, 2011 10:35 pm | by Bio-Medicine.Org | Comments

CHADDS FORD, Pa., Jan. 28, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology. The formation of this R&D...

TOPICS:

Decoding Pneumonia's Defenses

January 27, 2011 7:36 pm | by Massachusetts Institute of Technology | Comments

Researchers sequence more than 200 strains of the bug and find a catalog of ways they evade drugs and vaccines.

3 insurers agree to delay Calif rate increases(2)

January 27, 2011 4:46 pm | by DON THOMPSON - Associated Press - Associated Press | Comments

Customers of three California health insurers will get some breathing room after the companies agreed Thursday to delay rate increases for 60 days, isolating Blue Shield of California as the lone holdout.Anthem Blue Cross, Aetna and PacifiCare agreed to the delay to give the state Department of...

Advertisement

3 insurers agree to delay Calif rate increases

January 27, 2011 4:45 pm | Comments

Customers of three California health insurers will get some breathing room after the companies agreed Thursday to delay rate increases for 60 days, isolating Blue Shield of California as the lone holdout.Anthem Blue Cross, Aetna and PacifiCare agreed to the delay to give the state Department of...

Oklahoma to continue using sedative in executions

January 27, 2011 1:45 pm | by TIM TALLEY - Associated Press - Associated Press | Comments

Oklahoma prison officials will continue using a sedative as part of the state's three-drug lethal injection protocol despite objections from the drug's manufacturer, a spokesman for the state Department of Corrections said Thursday.Denmark-based Lundbeck, Inc., producer of the drug...

US state to continue using sedative in executions

January 27, 2011 1:45 pm | by TIM TALLEY - Associated Press - Associated Press | Comments

Oklahoma prison officials will continue using a sedative as part of the state's three-drug lethal injection protocol despite objections from the drug's manufacturer, a spokesman for the state Department of Corrections said Thursday.Denmark-based Lundbeck, Inc., producer of the drug...

Accuray Announces Results for Second Quarter of Fiscal 2011

January 27, 2011 1:36 pm | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Jan. 27, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010. For the second quarter of fiscal 2011, Accuray reported total...

TOPICS:

Surgical Information Systems Completes IHE North American Connectathon

January 27, 2011 1:36 pm | by Bio-Medicine.Org | Comments

ATLANTA, Jan. 27, 2011 /- Surgical Information Systems ("SIS"), a leader in perioperative information systems, announced today that it has successfully completed the healthcare industry's week-long interoperability testing event, Integrating the Healthcare Enterprise (IHE) Connectathon....

TOPICS:

Young Innovations, Inc. Provides 4th Quarter Conference Call Details

January 27, 2011 1:34 pm | by Bio-Medicine.Org | Comments

ST. LOUIS, Jan. 27, 2011 /- Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast its fourth quarter earnings results with a live and on-demand web cast conference call on Thursday, February 3, 2011 at 11:00 a.m. Central Time. A live audio broadcast of the call...

TOPICS:

Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer

January 27, 2011 1:33 pm | by Bio-Medicine.Org | Comments

BRIDGEWATER, N.J., Jan. 27, 2011 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and its subsidiary, BiPar Sciences, today announced that a randomized Phase III trial evaluating iniparib* (BSI-201) in patients with metastatic triple-negative breast cancer (mTNBC) did not meet the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading